SYL1001

DRUG3 trials

Sponsors

Sylentis, S.A.

Conditions

Dry EyeDry Eye SyndromeOcular Pain

Phase 1

Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers

CompletedNCT01438281

Sylentis, S.A.Dry Eye, Ocular Pain

Start: 2011-07-31End: 2012-06-30Updated: 2012-07-17

Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain

CompletedNCT01776658

Sylentis, S.A.Dry Eye Syndrome, Ocular Pain

Start: 2012-11-30Updated: 2015-05-25

Phase 2

Dose-finding Study to Assess the Safety and Effect of SYL1001 in Patients With Ocular Pain

CompletedNCT02455999

Sylentis, S.A.Dry Eye Syndrome, Ocular Pain

Start: 2015-06-30Updated: 2016-04-05

Related Papers

Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye Disease

Investigative Ophthalmology & Visual Science2016-11-2297 citations